GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors

NCT06077903 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated from a business perspective.

Conditions

Interventions

Sponsor

Grit Biotechnology